CAMBRIDGE, Mass., April 15, 2026 (GLOBE NEWSWIRE) — Wave Existence Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology corporate concerned with unlocking the huge attainable of RNA drugs to turn into human well being, nowadays introduced that its board of administrators has unanimously licensed a plan to redomicile the mum or dad corporate of the Wave Existence Sciences team of businesses from Singapore to america (the Redomiciliation).
Via Wave Existence Sciences’ list on Nasdaq, the vast majority of the corporate’s operations, its company headquarters, the vast majority of its running belongings, together with its production and analysis and construction amenities, together with the vast majority of its staff, control crew and board of administrators being in america, Wave already has a considerable U.S. presence. Having Wave’s mum or dad corporate domiciled in america will streamline Wave’s organizational, statutory and regulatory construction, leading to administrative efficiencies and decreasing twin monetary reporting, regulatory, criminal and different compliance prices, amongst different advantages.
“We believe the United States is the best place for Wave to enhance shareholder value. With several of our investigational therapies showing tremendous potential to become first- and/or best-in-class treatments, now is the right time and becoming a Delaware corporation is the right strategic move for Wave in order to better align our parent company’s domicile with our operations and our people,” stated Kyle Moran, Leader Monetary Officer of Wave Existence Sciences.
Matter to the receipt of vital Wave shareholder and Singapore Prime Court docket approvals, pursuant to the Redomiciliation transaction, the peculiar stocks of the prevailing Singapore mum or dad corporate (Wave Existence Sciences Ltd.) will likely be exchanged on a one-for-one foundation for not unusual inventory in a newly-formed Delaware mum or dad company (Wave Existence Sciences, Inc.). Wave Existence Sciences, Inc. will turn out to be without equal mum or dad corporate of the Wave Existence Sciences team of businesses and can function the industry of the gang in considerably the similar method as the corporate has carried out prior to now. Upon finishing touch of the Redomiciliation, the stocks of not unusual inventory of the brand new Delaware mum or dad company (Wave Existence Sciences, Inc.) will proceed to industry at the Nasdaq International Marketplace beneath Wave’s current buying and selling image “WVE”. The corporate will stay topic to the reporting necessities of the U.S. Securities and Change Fee (SEC) and the acceptable regulations of Nasdaq. Wave will proceed to record its consolidated monetary ends up in U.S. bucks and beneath U.S. in most cases authorized accounting ideas.
Wave is submitting its initial proxy fabrics with the SEC nowadays in preparation for an organization shareholder assembly to approve the Redomiciliation. The Redomiciliation is topic to the approval of Wave’s shareholders and the Singapore Prime Court docket. Matter to receiving the needful approvals, Wave expects the Redomiciliation to take impact in mid-2026. The Redomiciliation is anticipated to be tax-free to Wave’s U.S. shareholders.
About Wave Existence SciencesWave Existence Sciences (Nasdaq: WVE) is a biotechnology corporate concerned with unlocking the huge attainable of RNA drugs to turn into human well being. Wave’s RNA drugs platform, PRISM®, combines a couple of modalities, chemistry innovation and deep insights in human genetics to ship clinical breakthroughs that deal with each uncommon and not unusual issues. Its toolkit of RNA-targeting modalities, together with RNAi (SpiNA) and RNA enhancing (AIMers), supplies Wave with unrivaled functions for designing and sustainably turning in applicants that optimally deal with illness biology. Wave’s pipeline is concerned with its weight problems (WVE-007), alpha-1 antitrypsin deficiency (WVE-006) and PNPLA3 I148M liver illness (WVE-008) methods, and in addition contains medical methods in Duchenne muscular dystrophy and Huntington’s illness, in addition to a number of preclinical methods using the corporate’s flexible RNA drugs platform. Pushed via the calling to “Reimagine Possible,” Wave is main the price towards an international by which human attainable is now not hindered via the load of illness. Wave is headquartered in Cambridge, MA. For more info on Wave’s science, pipeline and other folks, please talk over with www.wavelifesciences.com and observe Wave on X and LinkedIn.
Ahead-Taking a look StatementsSome of the statements incorporated on this announcement would possibly come with “forward-looking statements” inside the which means of the Non-public Securities Litigation Reform Act of 1995, specifically, statements about our expectancies in regards to the alternate of the mum or dad corporate of the gang from a Singapore corporate to a Delaware company. Those statements come with, however don’t seem to be restricted to, statements that deal with our anticipated long run industry and statements in regards to the Redomiciliation and different statements recognized via phrases corresponding to “will”, “expect”, “believe”, “anticipate”, “estimate”, “should”, “intend”, “plan”, “potential”, “predict”, “project”, “aim”, and an identical phrases, words or expressions. Those forward-looking statements are according to present expectancies and ideology of the control of Wave Existence Sciences, in addition to assumptions made via, and knowledge recently to be had to, such control, present marketplace tendencies and marketplace prerequisites and contain dangers and uncertainties, a lot of which can be outdoor Wave Existence Sciences’ and control’s keep watch over, and which would possibly reason precise effects to range materially from the ones contained in ahead browsing statements. Accordingly, you will have to now not position undue reliance on such statements.
Specific uncertainties that would materially impact long run effects come with dangers related to the Redomiciliation, together with our talent to procure shareholder and Singapore Prime Court docket approvals and fulfill different remaining prerequisites to the finishing touch of the Redomiciliation inside the anticipated time frame or in any respect; our talent to comprehend the predicted advantages from the Redomiciliation; the incidence of difficulties or subject matter timing delays in reference to the Redomiciliation, together with any unanticipated prices in connection therewith; any delays, demanding situations and bills related to receiving governmental and regulatory approvals; adjustments in tax regulations, tax treaties or tax rules or the translation or enforcement thereof via the tax government in Singapore, america and different jurisdictions following the Redomiciliation; our essential accounting insurance policies; the facility of our preclinical research to provide information enough to reinforce the submitting of world medical trial programs and the timing thereof; our talent to proceed to construct and handle the corporate infrastructure and group of workers wanted to succeed in our objectives; the medical effects and timing of our methods, which would possibly not reinforce additional construction of our product applicants; movements of regulatory companies, which would possibly impact the initiation, timing and growth of medical trials; our effectiveness in managing present and long run medical trials and regulatory processes; the good fortune of our platform in figuring out viable applicants; the continuing construction and acceptance of nucleic acid therapeutics as a category of substances; our talent to reveal the healing advantages of our stereopure applicants in medical trials, together with our talent to expand applicants throughout a couple of healing modalities; our talent to procure, handle and give protection to highbrow assets; our talent to put into effect our patents in opposition to infringers and protect our patent portfolio in opposition to demanding situations from 3rd events; our talent to fund our operations and to lift further capital as wanted; festival from others growing remedies for an identical makes use of; and any affects on our industry because of or associated with any native and international well being epidemics, geopolitical conflicts, international financial uncertainty, the have an effect on of price lists and adjustments in financial insurance policies, volatility in inflation, volatility in rates of interest or marketplace disruptions on our industry.
The foregoing evaluate of essential components will have to now not be construed as exhaustive and will have to be learn together with the opposite cautionary statements which might be set forth in our most up-to-date Annual Document on Shape 10-Ok, Quarterly Experiences on Shape 10-Q and the opposite paperwork that we document with the SEC, together with beneath the heading “Risk Factors” in our most up-to-date Annual Document on Shape 10-Ok. Chances are you’ll download copies of those paperwork as described beneath the heading “Additional Information and Where to Find It.”
Further Data and The place to In finding ItIn reference to the Redomiciliation, Wave Existence Sciences expects to document with the SEC a proxy commentary and different related paperwork. The definitive proxy commentary will likely be mailed or another way disseminated to Wave Existence Sciences’ shareholders and can include essential details about the Redomiciliation. BEFORE MAKING ANY VOTING OR INVESTMENT DECISION, INVESTORS ARE URGED TO READ THE DEFINITIVE PROXY STATEMENT (INCLUDING ALL AMENDMENTS AND SUPPLEMENTS THERETO) AND OTHER RELEVANT DOCUMENTS FILED WITH THE SEC BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT WAVE LIFE SCIENCES LTD., WAVE LIFE SCIENCES, INC. AND THE REDOMICILIATION. Buyers would possibly download copies of the definitive proxy commentary (when to be had), in addition to different filings containing details about Wave Existence Sciences, at no cost, on the SEC’s Web web page (http://www.sec.gov). Copies of those paperwork will also be got at no cost from Wave Existence Sciences’ web page at www.wavelifesciences.com.
Contributors in SolicitationWave Existence Sciences and likely of its government officials and administrators could also be deemed to be individuals within the solicitation of proxies from the shareholders of Wave Existence Sciences in reference to the Redomiciliation. Details about the administrators and government officials of Wave Existence Sciences, together with an outline in their direct or oblique pursuits, via safety holdings or another way, is about forth in Wave Existence Sciences’ proxy commentary for its 2025 Annual Assembly of Shareholders, which was once filed with the SEC on June 23, 2025. To the level holdings of Wave Existence Sciences peculiar stocks via the administrators and government officials of Wave Existence Sciences have modified from the quantities of Wave Existence Sciences peculiar stocks held via such individuals as mirrored therein, such adjustments were or will likely be mirrored on Preliminary Statements of Really helpful Possession of Securities on Shape 3, Statements of Adjustments in Really helpful Possession on Shape 4 or Annual Statements of Adjustments in Really helpful Possession of Securities on Shape 5, in each and every case filed or to be filed with the SEC, as acceptable. Different data in regards to the individuals within the proxy solicitations and an outline in their direct and oblique pursuits, via safety holdings or another way, will likely be contained within the definitive proxy commentary when it’s filed with the SEC and different related fabrics to be filed with the SEC in regards to the Redomiciliation when such fabrics turn out to be to be had. Chances are you’ll download unfastened copies of those paperwork as described within the previous paragraph.
